155 related articles for article (PubMed ID: 11328789)
1. Efficacy of gatifloxacin alone and in combination with cefepime against penicillin-resistant Streptococcus pneumoniae in a rabbit meningitis model and in vitro.
Perrig M; Acosta F; Cottagnoud M; Gerber CM; Täuber MG; Cottagnoud P
J Antimicrob Chemother; 2001 May; 47(5):701-4. PubMed ID: 11328789
[TBL] [Abstract][Full Text] [Related]
2. Cefepime is efficacious against penicillin- and quinolone-resistant pneumococci in experimental meningitis.
Cottagnoud P; Acosta F; Cottagnoud M; Täuber MG
J Antimicrob Chemother; 2002 Feb; 49(2):327-30. PubMed ID: 11815575
[TBL] [Abstract][Full Text] [Related]
3. Synergy between trovafloxacin and ceftriaxone against penicillin-resistant pneumococci in the rabbit meningitis model and in vitro.
Cottagnoud P; Acosta F; Cottagnoud M; Neftel K; Täuber MG
Antimicrob Agents Chemother; 2000 Aug; 44(8):2179-81. PubMed ID: 10898696
[TBL] [Abstract][Full Text] [Related]
4. Efficacies of BMS 284756 against penicillin-sensitive, penicillin-resistant, and quinolone-resistant pneumococci in experimental meningitis.
Cottagnoud P; Acosta F; Cottagnoud M; Pfister M; Täuber MG
Antimicrob Agents Chemother; 2002 Jan; 46(1):184-7. PubMed ID: 11751131
[TBL] [Abstract][Full Text] [Related]
5. Trovafloxacin in combination with vancomycin against penicillin-resistant pneumococci in the rabbit meningitis model.
Rodoni D; Hänni F; Gerber CM; Cottagnoud M; Neftel K; Täuber MG; Cottagnoud P
Antimicrob Agents Chemother; 1999 Apr; 43(4):963-5. PubMed ID: 10103211
[TBL] [Abstract][Full Text] [Related]
6. Pharmacodynamics of gatifloxacin in experimental models of pneumococcal meningitis.
McCracken GH
Clin Infect Dis; 2000 Aug; 31 Suppl 2():S45-50. PubMed ID: 10984328
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of cefepime alone and in combination with vancomycin against penicillin-resistant pneumococci in the rabbit meningitis model and in vitro.
Gerber CM; Cottagnoud M; Neftel K; Täuber MG; Cottagnoud P
J Antimicrob Chemother; 2000 Jan; 45(1):63-8. PubMed ID: 10629014
[TBL] [Abstract][Full Text] [Related]
8. Pharmacodynamics of gatifloxacin in cerebrospinal fluid in experimental cephalosporin-resistant pneumococcal meningitis.
Lutsar I; Friedland IR; Wubbel L; McCoig CC; Jafri HS; Ng W; Ghaffar F; McCracken GH
Antimicrob Agents Chemother; 1998 Oct; 42(10):2650-5. PubMed ID: 9756771
[TBL] [Abstract][Full Text] [Related]
9. Grepafloxacin against penicillin-resistant pneumococci in the rabbit meningitis model.
Gerber CM; Tovar L; Cottagnoud M; Neftel KA; Täuber MG; Cottagnoud P
J Antimicrob Chemother; 2000 Aug; 46(2):249-53. PubMed ID: 10933648
[TBL] [Abstract][Full Text] [Related]
10. Gemifloxacin is efficacious against penicillin-resistant and quinolone-resistant pneumococci in experimental meningitis.
Cottagnoud P; Acosta F; Cottagnoud M; Täuber MG
Antimicrob Agents Chemother; 2002 May; 46(5):1607-9. PubMed ID: 11959614
[TBL] [Abstract][Full Text] [Related]
11. Meropenem alone and in combination with vancomycin in experimental meningitis caused by a penicillin-resistant pneumococcal strain.
Gerber CM; Cottagnoud M; Neftel KA; Täuber MG; Cottagnoud P
Eur J Clin Microbiol Infect Dis; 1999 Dec; 18(12):866-70. PubMed ID: 10691197
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of moxifloxacin, a new 8-methoxyquinolone, for treatment of meningitis caused by a penicillin-resistant pneumococcus in rabbits.
Ostergaard C; Sørensen TK; Knudsen JD; Frimodt-Møller N
Antimicrob Agents Chemother; 1998 Jul; 42(7):1706-12. PubMed ID: 9661008
[TBL] [Abstract][Full Text] [Related]
13. Trovafloxacin in treatment of rabbits with experimental meningitis caused by high-level penicillin-resistant Streptococcus pneumoniae.
Kim YS; Liu Q; Chow LL; Täuber MG
Antimicrob Agents Chemother; 1997 May; 41(5):1186-9. PubMed ID: 9145898
[TBL] [Abstract][Full Text] [Related]
14. Ceftriaxone acts synergistically with levofloxacin in experimental meningitis and reduces levofloxacin-induced resistance in penicillin-resistant pneumococci.
Flatz L; Cottagnoud M; Kühn F; Entenza J; Stucki A; Cottagnoud P
J Antimicrob Chemother; 2004 Feb; 53(2):305-10. PubMed ID: 14729741
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of gatifloxacin in experimental Escherichia coli meningitis.
Lutsar I; Friedland IR; Jafri HS; Wubbel L; Ng W; Ghaffar F; McCracken GH
Antimicrob Agents Chemother; 1999 Jul; 43(7):1805-7. PubMed ID: 10390250
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of gatifloxacin alone and in combination with cefepime, meropenem, piperacillin and gentamicin against multidrug-resistant organisms.
Dawis MA; Isenberg HD; France KA; Jenkins SG
J Antimicrob Chemother; 2003 May; 51(5):1203-11. PubMed ID: 12697632
[TBL] [Abstract][Full Text] [Related]
17. Anti-pneumococcal activity of gatifloxacin compared with other quinolone and non-quinolone agents.
Hoellman DB; Lin G; Jacobs MR; Appelbaum PC
J Antimicrob Chemother; 1999 May; 43(5):645-9. PubMed ID: 10382885
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of T-3811ME (BMS-284756), a new des-F(6)-quinolone, for treatment of meningitis caused by penicillin-resistant Streptococcus pneumoniae in rabbits.
Takahata M; Yamada H; Morita T; Furubou S; Minami S; Todo Y; Watanabe Y; Narita H
Antimicrob Agents Chemother; 2002 Jun; 46(6):1760-5. PubMed ID: 12019087
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of CP-99,219, a new fluoroquinolone, for treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis.
París MM; Hickey SM; Trujillo M; Shelton S; McCracken GH
Antimicrob Agents Chemother; 1995 Jun; 39(6):1243-6. PubMed ID: 7574509
[TBL] [Abstract][Full Text] [Related]
20. In vivo pharmacodynamic efficacy of gatifloxacin against Streptococcus pneumoniae in an experimental model of pneumonia: impact of the low levels of fluoroquinolone resistance on the enrichment of resistant mutants.
Croisier D; Etienne M; Piroth L; Bergoin E; Lequeu C; Portier H; Chavanet P
J Antimicrob Chemother; 2004 Sep; 54(3):640-7. PubMed ID: 15317743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
